The value of disease management - Approaching the industrialisation of modern medicine

被引:4
作者
Berger, ML
Nebenfuhr, P
Murray, RK
机构
[1] Merck & Co Inc, Outcomes Res & Management, W Point, PA 19486 USA
[2] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[3] Univ N Carolina, Sch Publ Hlth, Dept Hlth Policy & Adm, Chapel Hill, NC USA
[4] Merck & Co Inc, Hlth Management Serv, W Point, PA USA
[5] Merck & Co Inc, Reg Med Director Program, W Point, PA USA
关键词
D O I
10.2165/00115677-200008040-00001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Recent years have seen the beginning of an industrial revolution in healthcare delivery. Healthcare is being transformed from a cottage industry, in which each provider sets individual standards, to a quality-controlled enterprise with common, evidence-based standards of care. Disease management is fundamental to this transformation; it is based on the application of the industrial engineering principle of 'total quality management' to healthcare as 'continuous quality improvement'. As little evidence has been published in the peer-reviewed literature regarding the cost effectiveness of disease management, specific disease management programmes should be judged by the extent to which its design adheres to the principles of continuous quality improvement. Disease: management should, furthermore, be integrated into the overall activities of the healthcare system rather than being a carve-out offering. The true value of disease management is as a paradigm by which the healthcare system can re-engineer how it goes about its business - with clear goals, recognised standards and ongoing monitoring. The adoption of evidence-based best practice guidelines and the attendant reduction in practice variation will inevitably benefit millions of patients.
引用
收藏
页码:181 / 184
页数:4
相关论文
共 8 条
[1]   A population-based approach to asthma disease management [J].
Algatt-Bergstrom, PJ ;
Markson, LE ;
Murray, RK ;
Berger, ML .
DISEASE MANAGEMENT & HEALTH OUTCOMES, 2000, 7 (04) :179-186
[2]   Disease management programs [J].
Armstrong, EP ;
Langley, PC .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (01) :53-58
[3]   CONTINUOUS IMPROVEMENT AS AN IDEAL IN HEALTH-CARE [J].
BERWICK, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (01) :53-56
[4]   Disease management in the American market [J].
Bodenheimer, T .
BRITISH MEDICAL JOURNAL, 2000, 320 (7234) :563-566
[5]  
*CTR EV CLIN SCI, 1999, DARTM ATL HLTH CAR
[6]   THE QUALITY OF CARE - HOW CAN IT BE ASSESSED [J].
DONABEDIAN, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (12) :1743-1748
[7]  
McLaughlin C.P., 1994, Continuous quality improvement in health care
[8]   Heart failure disease management: A critical review [J].
Rich, MW .
JOURNAL OF CARDIAC FAILURE, 1999, 5 (01) :64-75